Atlas Trials

Panhematin for Prevention of Acute Attacks of Porphyria

Clinical trial NCT02922413 · TERMINATED

Trial details

NCT number
NCT02922413
Sponsor
The University of Texas Medical Branch, Galveston
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Intermittent PorphyriaHereditary CoproporphyriaVariegate Porphyria
Start date
2015-10-30
Primary completion
2023-12-27
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.